Page 19 - Breakthrough Device News Today

/PRNewswire/ -- Datar Cancer Genetics Inc announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its...

The liquid biopsy has been developed by Datar Cancer Genetics to help diagnose brain tumors where a conventional biopsy is not possible. A prospective, blinded study by a research team

Synchron, the endovascular brain-computer interface company, announced today an oversubscribed $75 million Series C financing round.

Australian Tom Oxley’s Synchron has become the centre of attention for three of the world’s richest people.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its...

Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, today announces its Health Tech portfolio company OxfordVR, a leader in virtual reality (VR) treatments for serious mental ...

/PRNewswire/ -- CB Insights today announced that, for the second year in a row, MedRhythms has been named to its annual Digital Health 150, a list that...

Corvia Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., Dec. 6, 2022 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming

—Data Presented at CTAD Conference Shows that AlzoSure® Predict Can Accurately Identify Stage of Cognitive Decline and Predict Whether Individuals Will...